Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Disc Medicine to Participate in Upcoming Investor Conferences
-
Disc Medicine (IRON) Reiterated at Overweight by Cantor Fitzgerald on Selcodebart Potential
-
Disc Medicine (IRON) Reiterated at Overweight by Cantor Fitzgerald
-
Disc Medicine (IRON) PT Lowered to $125 at Cantor Fitzgerald, Overweight Rating Maintained
-
Disc Medicine prices $250 million stock offering at $84 per share
-
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
-
Disc Medicine announces $220M public stock offering
-
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Disc Medicine (IRON) PT Raised to $153 at Cantor Fitzgerald After FDA Priority Voucher Win
-
Disc Medicine to Participate in Upcoming Investor Conferences
-
Cantor Fitzgerald Reiterates Overweight Rating on Disc Medicine (IRON)
-
Cantor Fitzgerald Reiterates Overweight Rating on Disc Medicine (IRON)
-
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
-
Disc Medicine (IRON) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
